Pharmacogenomics and medication overuse headache: when the cure may turn to poison

Medication overuse headache (MOH) is a secondary form of chronic headache (occur­ ing > 15 days/month), usually developed in migraine patients after regular symptomatic drug overuse (1,2). Prevalence is about 1.5-3% of gen­ eral population, whereas in headache clinics it